VIM and breast cancer: On the contrary, vimentin, an intermediate filament protein characteristically upregulated in cells undergoing EMT, plays a key role in the motility and migration of breast cancer cells as it is also highly expressed at the wound edge in mammary epithelial cells and breast cancer cells [59,60].